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 1 
Summary: This overview critically appraises and summarises and the key findings of 
six systematic reviews of interventions for preventing/managing radiation dermatitis. 
This overview provides direction for an up-to-date high quality systematic review to 
be conducted to guide practice and direct future research. 
 
*Summary
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ABSTRACT 
Purpose: To provide an overview and a critical appraisal of systematic reviews (SRs) 
published on interventions for the prevention/management of radiation dermatitis.  
Methods and Materials: We searched the following electronic databases: MEDLINE, 
CINAHL, EMBASE, and the Cochrane Library. We also hand-searched reference lists of 
potentially eligible articles and a number of key journals in the area. Two authors 
screened all potential articles and included eligible SRs. Two authors critically appraised 
and extracted key findings from the included reviews using the “A Measurement Tool to 
Assess Systematic Reviews” (AMSTAR). 
Results: Of 1837 potential titles, six SRs were included. A number of interventions have 
been reported to be potentially beneficial for managing radiation dermatitis. Interventions 
evaluated in these reviews included skin care advice, steroidal/non-steroidal topical 
agents, systematic therapies, modes of radiation delivery, and dressings. However, all the 
included SRs reported that there is insufficient evidence supporting any single effective 
intervention. The methodological quality of the included studies varied, and 
methodological shortfalls in these reviews may create biases to the overall results or 
recommendations for clinical practice. 
Conclusions:  An up-to-date high quality SR in preventing/managing radiation dermatitis 
is needed to guide practice and direction for future research. Clinicians or guideline 
developers are recommended to critically evaluate the information of SRs in their 
decision making.    
 
*BLINDED Manuscript (No Author Details)
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INTRODUCTION 
Despite advances in understanding of the pathophysiology (1), radiologic techniques (2, 3) 
and other various interventions of radiation dermatitis, the prevalence of this condition 
remains high in cancer patients undergoing radical radiation treatment, with more than 
90% experiencing erythema and  more than 30% experiencing moist desquamation (3, 4). 
To date, there is a lack of conclusive evidence to inform best management and there is a 
large variation in the clinical management of this condition (5, 6). Although systematic 
reviews (SRs) have the potential to effectively inform this area of practice, no work has 
been conducted to evaluate the SR in this area. 
Systematic reviews are increasingly used as the standard approach in summarizing health 
research and influence health care decisions (7).  It is therefore important to ensure that 
the standards of SRs are maintained (8), so clinicians and policy makers can make timely 
and effective health care decisions (9, 10). To ensure the quality of SRs, overviews of SR 
are increasingly used in medicine (8, 11, 12). These overviews are intended primarily to 
summarise and critically appraise multiple reviews addressing the effect of two or more 
potential interventions for a single condition or health problem (11). From Dec 2011 to 
Mar 2012, we conducted an overview by reviewing the scope/ key findings of SRs 
published on interventions for prevention/management of radiation dermatitis; evaluating 
the quality of these SRs using a validated scale, and report on the direction of clinical 
conclusions (effectiveness); and highlighting some methodological and reporting issues 
of the SRs. 
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METHODS AND MATERIALS 
Searching of relevant reviews 
Systematic reviews published on prevention/management of radiation dermatitis were 
identified by literature search of MEDLINE, EMBASE, CINAHL, and the Cochrane 
Library (up to Feb 2012). The initial search strategy was designed for MEDLINE (Supp 
1). The reference lists of all potentially eligible articles were reviewed for SRs. We also 
hand-searched a number of key journals  including International Journal of Radiation 
Oncology, Biology, Physics, Radiation Oncology, International Journal of Radiation 
Oncology, Journal of Pain and Symptom Management, Journal of Integrative Cancer 
Therapies, and Cancer Nursing. Authors of the SRs were not contacted. 
 
All citations were reviewed independently by two authors for inclusion in this overview. 
Disagreements were resolved by consensus. A citation was considered relevant for this 
overview using the following criteria: 
- The primary aim was reviewing the efficacy of interventions for preventing and 
managing radiation dermatitis, and was stated in the title; abstract or the article. 
- The article was described as “systematic review”, “systematic overview”, 
“quantitative review”, “systematic literature review” or “meta-analysis”. 
- The article was published in a peer reviewed publication. Unpublished work, 
abstracts, letters and conference proceedings were excluded. No language 
exclusion was applied. 
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 INSERT TABLE 1 
 
Evaluation of systematic reviews 
An 11-question Measurement Tool to Assess Systematic Review (AMSTAR) was used to 
appraise the SRs (Supp2) (13). AMSTAR was reported to demonstrate good agreement, 
reliability, construct validity and feasibility (13). Two reviewers independently appraised 
the included reviews using AMSTAR, and judged each item as “Yes, No, Can’t Answer 
or Not applicable”. Any discrepancies were resolved by consensus. The methodological 
quality, the characteristics, and finding summaries of the included SRs are extracted by 
two authors (Table 1). Reviews achieving a score of 8-11 are deemed to be high 
methodological quality, 4-7  to be medium and 0-3 to be low (12). 
 
 
RESULTS 
The initial search yielded 1837 titles of potential interest. We reviewed abstracts of these 
titles and identified 105 for further consideration with full papers being obtained. We 
included six SRs with the objectives and outcomes of interest to this current paper (14-19) 
(See Table 1).  
 
INSERT TABLE 1 
 
Description of included reviews 
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All reviews (n=6) examined the efficacy of interventions for the prevention/management 
of radiation dermatitis (14-19). The number of included studies ranged from five studies 
to 39 studies in each review. These reviews varied in their scope including participants, 
intervention, comparison and outcomes of interest. Two reviews concerned any 
interventions for all cancer patients with radiation dermatitis (14, 17). One examined skin 
care advice in relation to the use of washing agents and other topical agents given to 
patients with breast cancer undergoing radiotherapy (18). One examined interventions for 
patients who developed moist desquamation (15). One compared aloe vera gel with other 
interventions for patients with radiation dermatitis (16). One examined anti-inflammatory 
creams in patients with post radiation acute skin reactions (19). Only one review did not 
have a language restriction (16). Four reviews (14, 17-19) planned to exclude non-
English studies, and another one (15) planned to search for non-English studies, but did 
not translate some non-English studies due to financial constraint. 
 
With regards to outcomes, the grading of skin reactions was measured in all reviews. Pain, 
itching, burning and quality-of-life were measured in two reviews (14, 17, 19). Other 
outcomes of interest included healing time (15), patient comfort/acceptability (15), 
patient perspectives (17). No meta-analysis was conducted in any of the included reviews. 
Two reviews (14, 15) provided a reason for not pooling data, due to the clinical 
heterogeneity of the included studies. One review planned to conduct a narrative review 
and not to pool data (17). The other three reviews did not provide any reasons for not 
pooling data (16, 18, 19).  
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Methodological quality of included reviews 
The AMSTAR scores for the six reviews ranged from three to eight out of the total score 
of 11. One review scored eight (16), one scored six (17), two scored five (14, 15), and 
two scored three (18, 19) (see Supp 3).  All reviews provided a priori design and 
conducted comprehensive searches with main databases searched. Three reviews 
performed duplicate study extraction and study selection (14, 16, 17). Three reviews used 
the status of publication (i.e. grey literature) as an inclusion criterion (15-17). Lists of 
included and excluded studies were provided in three reviews (14, 16, 17). Of the six 
reviews, only one listed the characteristics of participants (i.e. age, treatment sites, dosage  
etc) (16). Two reviews assessed the scientific quality of the included studies, and used 
them appropriately in formulating conclusions (15, 16). Two reviews reported that 
authors did not have any potential conflicts of interest (17, 19). The other four did not 
report any potential conflicts of interest (14-16, 18). No reviews performed/reported any 
assessment for publication bias.  
 
Key findings of the included reviews 
Skin care advice 
Four reviews examined washing practices for preventing radiation dermatitis (14, 17-19). 
All four reviews concluded that gentle skin and hair washing with mild soap should not 
be restricted in patients receiving radiation therapy (14, 17-19). However, it was unclear 
how “mild” soap was defined (14, 19). Two reviews examined whether deodorants 
should be used in patients with radiation dermatitis (18).  Bucher et al (2011) concluded 
that deodorant use remained an inconclusive area. The use of non-metallic deodorants 
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does not seem to adversely affect patient’s skin reactions (18). Koukourakis et al (2010) 
further challenged the assumption about a potential bolus effect from metallic or non-
metallic deodorants and concluded that patients could use deodorant on intact skin 
throughout treatment based on the results of one non-clinical study (19, 20).   
 
Topical agents (Steroidal) 
Four reviews examined the effects of steroidal topical agents (14, 17-19). These reviews 
reported that a number of steroidal topical agents including mometasone furoate cream, 
methylprenisolone aceponate cream, beclomethasone can significantly improve radiation 
dermatitis (14, 17-19). However, the use of steroidal agents is limited because they can 
cause thinning of the skin and introduce bacterial infections (18). 
 
Topical agents (Non-steroidal) 
Five reviews examined a range of non-steroidal topical agents (14, 16-19). Sucralfate/ 
sucralfate derivatives were reported to make no difference in severity of the reaction, 
when comparing with placebo or aqueous cream (14, 17, 19). Biafine cream®, an oil-in-
water emulsion with non-steroidal anti-inflammatory properties, were reported by three 
reviews to not be superior over a number of comparators including aloe vera, Lipiderm 
cream® and Avene thermal spring water anti-burning gel ® (14, 17, 19). When 
comparing with the Biafine cream and calendula ointment, patients receiving calendula 
ointment had significantly fewer occurrences of dermatitis higher than grade 2, and 
greater pain relief (14, 17). However, two reviews did not recommend calendula ointment 
due to the difficulty in application and the potential bias in the trial (14, 19). 
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Four reviews examined aloe vera (14, 16, 17, 19). These reviews concluded that there is 
no evidence suggesting aloe vera to be effective for the prevention/management of 
radiation dermatitis in both adults and children (14, 16, 17, 19). Further, aloe vera was 
less effective when comparing with an anionic phospholipid-based cream and aqueous 
cream (16). Xclair, an hyaluronidase-based cream, was reported by two reviews to be 
effective in reducing the occurrences of radiation dermatitis and burning, but not in 
improving pain or itching (17, 19). Two reviews reported contradictory results or 
uncertain benefits with regards to the use of hyaluronic acid cream (14, 19). 
 
Systematic therapies 
Two reviews examined amifostine, oral enzymes, pentoxifyiline and zinc supplements 
(14, 17). Amifostine, oral enzymes, pentoxifyiline and zinc supplements were reported to 
significantly reduce the maximum extent of radiation dermatitis at some time point 
during or after radiation treatment (14, 17). The results were supported by small number 
of trials, and further research is required. The side effects associated with oral enzymes 
also deserve further consideration in clinical practice and future research (14). 
 
Mode of radiation delivery 
One review examined mode of radiation delivery (17). Salvo et al (2010) reported that 
intensity-modulated radiation therapy (IMRT) was reported to significantly reduce moist 
desquamation in patients with radiation dermatitis, compared to standard method of 
delivering radiotherapy. Patients receiving IMRT with light-emitting diode (LED) photo-
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modulation were also reported to have significantly reduced dry and moist desquamation 
compared to those receiving IMRT alone (17). 
 
Dressings 
Four reviews examined the use of dressings (14, 15, 17, 19). These reviews concluded 
that there is limited evidence investigating the efficacy of dressings (14, 15, 17, 19). 
Kedge suggested there may be advantages to use the moisture-vapour permeable dressing 
(MVPD). However, further research is necessary as there is not yet sufficient evidence 
supporting MVPD (15). Salvo et al (2010) reported that hydrogel dressing is not 
beneficial for radiation dermatitis as it had a significantly longer healing time, compared 
to the use of dry dressing (17). When comparing hydrogel dressing and gentian violet in 
the management of moist desquamation, wound size and wound pain was significantly 
lower with gentian violet (14, 17). However, there is no evidence supporting gentian 
violet in terms of healing time, pain and comfort, and there are safety and patient comfort 
concerns associated with its use (15). Silver-leaf nylon dressings were reported to be 
superior over silver sulfadiazine cream in reducing skin reactions and pain (17, 19). 
 
 
DISCUSSION 
This is the first overview of SRs concerning efficacy of interventions for preventing or 
managing radiation dermatitis. This overview confirms that there is insufficient evidence 
to support the use of a particular intervention for preventing/ managing radiation 
dermatitis. To date, the literature in this area shows a majority of negative results. 
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Researchers must ensure that the highest methodological standard possible is upheld for 
every level of research reports to avoid any bias to the results for clinical 
recommendations. This overview focused on the highest level of evidence (SRs) and 
revealed a number of methodological issues. When a review is listed to be a SR, the 
respective components and standards should be expected (11). Only one of the six SRs 
was judged to be high quality (16). However, the scope of this high quality review was 
limited to aloe vera use and was conducted in 2004. A number of important outcomes 
including pain, itching and quality-of-life were not included by some reviews, but should 
be incorporated in future SRs in this area. The inclusion of these important outcomes will 
enable the detection of any selective reporting bias in clinical trials. Shortfalls in the 
methodological quality of these reviews may have direct implications on the clinical 
conclusions made in each review. For example, Koukourakis et al (2010) set a priori 
decision to only include English controlled trials (19), however, this review used non-
controlled studies to formulate their conclusions. In particular, despite much debate in the 
area of deodorant use during radiation treatment, this review (19) made a conclusion of 
recommending deodorant use on intact skin throughout treatment based on the results of 
one non-clinical study. 
 
Further, it was unclear whether duplicate study selection was conducted in three included 
reviews (15, 18, 19). This could directly compromise the quality of the searching process 
and miss studies that fit the inclusion criteria of some of the reviews. For example, we 
noticed that some controlled trials identified in the search of this overview to be 
appropriate, but were not included in any of the included reviews (21-23). If the review 
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authors excluded any irrelevant studies on any grounds, they should list the excluded 
studies with reasons given. 
 
The language restriction to English in the majority of the included reviews could increase 
the risk of reporting bias (24), because statistically significant, ‘positive’ results that 
indicate an intervention works are more likely to be published in English (24). Further, 
there has been an increasing evidence base for some of the complementary and 
alternative cancer treatments, which are more likely to be reported in a non-English 
language such as acupuncture (25, 26). Indeed, two RCTs with positive results were also 
located through the search conducted in this overview (27, 28). These articles should be 
taken into consideration, appraised/reviewed according to their quality. It is noteworthy 
that publication biases can be a significant issue that deserves investigation in all SRs 
(24).   
 
An established definition of prevention/prophylaxis and treatment should be suggested 
for future trialists/review authors to consider. This will have enormous implications on 
the pooling of data across trials. We suggest that true “prevention” should be reserved for 
use if the trialists/review authors aim to prevent a reaction from occurring (yes/no) (29). 
The delaying of skin reactions may not mean that the toxicity is less severe throughout 
treatment and week/months post-treatment. While it may be difficult to achieve true 
prevention, clinicians and researchers have a responsibility to aim for this. “Treatment” 
should be used to refer to any other management strategies after the onset of any graded 
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radiation dermatitis. If the trial authors have a priori aim to prevent a particular grade of 
dermatitis, this should be specified clearly at the outset. 
 
The included reviews reported a number of useful findings that deserve further 
investigations. However, the methodological/reporting flaws require further 
improvements. It is advised that a high quality over-arching SR should be conducted 
investigating the effects of prevention/management of radiation dermatitis. The review 
should include all important outcomes. This review should be updated regularly to aid 
timely decision making of health professionals who have to confront this medical 
condition on a daily basis. 
 
 
CONCLUSION 
There is a high variability in the quality and scope of the SRs concerning the management 
of radiation dermatitis. Several common methodological/reporting shortfalls in the 
included reviews were identified in this overview. These included the omission of 
duplicate selection of studies, publication bias assessment, and declaration of conflict of 
interest in some reviews. The methodological shortfalls identified may have created 
biases to the overall results or recommendations for clinical practice. This overview 
provides a direction for an up-to-date high quality systematic review in managing 
radiation dermatitis in patients with cancer to be conducted. Clinicians or guideline 
developers are recommended to critically evaluate the information in the SRs in their 
decision making. 
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